4.585
price down icon2.65%   -0.125
 
loading
JanOne Inc stock is currently priced at $4.585, with a 24-hour trading volume of 57,237. It has seen a -2.65% decreased in the last 24 hours and a +91.04% rose in the past month. The chart indicates a potential bearish trend, as the stock is below the $4.68 pivot point. If it approaches the $4.48 support level, significant changes may occur.
Previous Close:
$4.71
Open:
$4.61
24h Volume:
57,237
Market Cap:
$40.48M
Revenue:
$40.02M
Net Income/Loss:
$12.88M
P/E Ratio:
1.3213
EPS:
3.47
Net Cash Flow:
$1.21M
1W Performance:
+15.49%
1M Performance:
+91.04%
6M Performance:
+1,268%
1Y Performance:
+386.21%
1D Range:
Value
$4.585
$4.89
52W Range:
Value
$0.2204
$5.08

JanOne Inc Stock (JAN) Company Profile

Name
Name
JanOne Inc
Name
Phone
702 997 5968
Name
Address
325 East Warm Springs Road, Suite 102, Las Vegas, NV
Name
Employee
161
Name
Twitter
@JanOne
Name
Next Earnings Date
2024-05-22
Name
Latest SEC Filings
Name
JAN's Discussions on Twitter

JanOne Inc Stock (JAN) Financials Data

JanOne Inc (JAN) Revenue 2024

JAN reported a revenue (TTM) of $40.02 million for the quarter ending December 31, 2021.
loading

JanOne Inc (JAN) Net Income 2024

JAN net income (TTM) was $12.88 million for the quarter ending September 30, 2023, a +485.92% increase year-over-year.
loading

JanOne Inc (JAN) Cash Flow 2024

JAN recorded a free cash flow (TTM) of $1.21 million for the quarter ending September 30, 2023, a +127.89% increase year-over-year.
loading

JanOne Inc (JAN) Earnings per Share 2024

JAN earnings per share (TTM) was $4.05 for the quarter ending September 30, 2023, a +304.55% growth year-over-year.
loading
JanOne Inc., a clinical-stage biopharmaceutical company, focuses on identifying, acquiring, licensing, developing, partnering, and commercializing novel, non-opioid, and non-addictive therapies to address the unmet medical need for the treatment of pain and addiction. It operates through three segments: Biotechnology, Recycling, and Technology. The company's lead product candidate is JAN101, a patented oral and sustained release pharmaceutical composition of sodium nitrite that targets poor blood flow to the extremities in patients with diabetes or peripheral artery disease to treat pain. It also provides turnkey appliance recycling and replacement services for utilities and other sponsors of energy efficiency programs; and designs, develops, and sells cellular transceiver modules and associated wireless services. The company was formerly known as Appliance Recycling Centers of America, Inc. and changed its name to JanOne Inc. in September 2019. JanOne Inc. was founded in 1976 and is headquartered in Las Vegas, Nevada.
$2.165
price up icon 4.59%
$8.11
price up icon 0.87%
waste_management MEG
$42.82
price up icon 3.72%
$46.23
price down icon 0.61%
$90.81
price down icon 3.72%
waste_management CLH
$193.74
price down icon 0.29%
Cap:     |  Volume (24h):